tiprankstipranks
Advertisement
Advertisement

LKFT Stock Latest News

Lakefront Biotherapeutics Details June Share Buybacks Under Ongoing Repurchase Program
Company AnnouncementsLakefront Biotherapeutics Details June Share Buybacks Under Ongoing Repurchase Program
2d ago
6K
LKFT
Lakefront Biotherapeutics Discloses New 5% Stake by Madison Avenue Partners
PremiumCompany Announcements
Lakefront Biotherapeutics Discloses New 5% Stake by Madison Avenue Partners
3d ago
6K
LKFT
Lakefront Biotherapeutics Buys Back 77,667 Shares Under June 2026 Repurchase Program
PremiumCompany Announcements
Lakefront Biotherapeutics Buys Back 77,667 Shares Under June 2026 Repurchase Program
9d ago
6K
LKFT
Lakefront Biotherapeutics Details June Share Buybacks Under New Repurchase Program
PremiumCompany Announcements
Lakefront Biotherapeutics Details June Share Buybacks Under New Repurchase Program
16d ago
6K
LKFT
Lakefront Biotherapeutics announces EUR 50M share repurchase program
PremiumThe Fly
Lakefront Biotherapeutics announces EUR 50M share repurchase program
23d ago
LKFT
Lakefront Biotherapeutics appoints Eric Hedrick chief medical officer
PremiumThe FlyLakefront Biotherapeutics appoints Eric Hedrick chief medical officer
24d ago
LKFT
Lakefront Biotherapeutics and Gilead Close Ouro Medicines Deal, Anchor Autoimmune Pipeline Around Gamgertamig
Premium
Company Announcements
Lakefront Biotherapeutics and Gilead Close Ouro Medicines Deal, Anchor Autoimmune Pipeline Around Gamgertamig
28d ago
6K
LKFT
Lakefront Biotherapeutics Discloses Bank of America Building 9.3% Stake
Premium
Company Announcements
Lakefront Biotherapeutics Discloses Bank of America Building 9.3% Stake
1M ago
6K
LKFT
Lakefront Biotherapeutics Bets Big on Ouro Pivot
PremiumCompany Announcements
Lakefront Biotherapeutics Bets Big on Ouro Pivot
1M ago
LKFT
Dermatomyositis Trial Update Sets Context For LKFT’s Autoimmune Pipeline
PremiumCompany Announcements
Dermatomyositis Trial Update Sets Context For LKFT’s Autoimmune Pipeline
2M ago
LKFT
Lakefront Biotherapeutics Spotlight: Completed Phase 2 Lupus Study Sets Stage for Key Data Catalyst
PremiumCompany Announcements
Lakefront Biotherapeutics Spotlight: Completed Phase 2 Lupus Study Sets Stage for Key Data Catalyst
2M ago
LKFT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >